基本資料
種類: ETF
費用比率%: 0.79
資產淨值: 84.97
成立日期: 16/12/2014
 
分析
市值分佈:
58.79%
大市值
24.60%
中市值
9.76%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 57  
0%
 
100%
     10大 (25.53%)
代號 名稱 佔比% 持有日期
IBRXImmunityBio6.1927/02/2026
MRNAModerna2.7227/02/2026
IOVAIovance Biotherapeutics2.6227/02/2026
NVAXNovavax2.3127/02/2026
MIRMMirum Pharmaceuticals2.1227/02/2026
FOLDAmicus Therapeutics2.0327/02/2026
ROIVRoivant Sciences Ltd1.9627/02/2026
DAWNDay One Biopharmaceuticals1.8927/02/2026
GILDGilead Sciences1.8527/02/2026
GERNGeron Corp1.8427/02/2026
AMGNAmgen1.8227/02/2026
BNTXBioNTech SE American Depositary Share1.7427/02/2026
BMRNBioMarin Pharmaceutical1.7327/02/2026
BCRXBioCryst Pharmaceuticals1.7327/02/2026
KRYSKrystal Biotech1.6827/02/2026
HALOHalozyme Therapeutics1.6727/02/2026
AGIOAgios Pharmaceuticals1.6627/02/2026
AXSMAxsome Therapeutics1.6527/02/2026
BIIBBiogen1.6527/02/2026
VRTXVertex Pharmaceuticals1.6427/02/2026
 1    2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.